Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0012627250
Tue, 01.04.2025
HBM Healthcare Investments AG
In a market environment that remains difficult for the biotech sector, HBM Healthcare Investments closed the 2024/2025 financial year with a net profit of CHF 19 million as of 31 March. Net asset value per share (NAV) rose by 1.5 percent to CHF 244.41. The share price fell slightly by 2.6 percent.
Some of the relevant healthcare sector [ … ]
Thu, 20.03.2025
HBM Healthcare Investments AG
Further validation of the pioneering science and innovation of the US-based biotech company;
Transaction increases NAV per HBM share by CHF 8.70 (+3.6%); expected cash inflow of USD 50 million for HBM Healthcare Investments from the upfront amount.
HBM Healthcare Investments (SIX: HBMN) today announced that Dren Bio, a private portfolio company, a [ … ]
Mon, 20.01.2025
HBM Healthcare Investments AG
Profit of CHF 66 million in the first nine months
NAV up 4.3 percent, share price down 5.2 percent, discount widens to just under 30 percent
Private portfolio companies as main profit drivers
Positive result for the first nine months ended 31 December 2024
HBM Healthcare Investments generated a profit of CHF 66 million in the first nine mont [ … ]
Fri, 03.01.2025
HBM Healthcare Investments AG
HBM Healthcare Investments closed the calendar year 2024 with a strong performance. Its net asset value (NAV) per share rose by 15 percent to CHF 251.17. By contrast, the share price failed to reflect this good performance, growing only marginally by 0.5 percent to CHF 176.00. The market capitalisation is thus almost 30 percent or more than CHF 500 [ … ]